Viewing Study NCT00003056


Ignite Creation Date: 2025-12-24 @ 11:21 PM
Ignite Modification Date: 2026-02-23 @ 12:22 PM
Study NCT ID: NCT00003056
Status: TERMINATED
Last Update Posted: 2021-05-06
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation
Sponsor: Baxalta now part of Shire
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Lymphoma View
None Graft Versus Host Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult diffuse small cleaved cell lymphoma View
None adult acute myeloid leukemia in remission View
None recurrent grade 2 follicular lymphoma View
None accelerated phase chronic myelogenous leukemia View
None adult acute lymphoblastic leukemia in remission View
None recurrent grade 1 follicular lymphoma View
None recurrent adult lymphoblastic lymphoma View
None recurrent marginal zone lymphoma View
None chronic phase chronic myelogenous leukemia View
None recurrent small lymphocytic lymphoma View
None recurrent grade 3 follicular lymphoma View
None recurrent adult Hodgkin lymphoma View
None recurrent adult acute lymphoblastic leukemia View
None recurrent adult immunoblastic large cell lymphoma View
None graft versus host disease View
None recurrent adult diffuse mixed cell lymphoma View
None recurrent mantle cell lymphoma View
None splenic marginal zone lymphoma View
None recurrent adult acute myeloid leukemia View
None extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
None recurrent adult diffuse large cell lymphoma View
None nodal marginal zone B-cell lymphoma View
None recurrent adult Burkitt lymphoma View